NUS Fundamental Analysis - NUSCO SPA

Fundamental Rating

Overall NUS gets a fundamental rating of 2 out of 10. We evaluated NUS against 27 industry peers in the Building Products industry. NUS has a bad profitability rating. Also its financial health evaluation is rather negative. NUS has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

NUS had negative earnings in the past year.

NUS had a positive operating cash flow in the past year.

Of the past 5 years NUS 4 years were profitable.

The reported operating cash flow has been mixed in the past 5 years: NUS reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.28%, NUS is doing worse than 81.48% of the companies in the same industry.

With a Return On Equity value of -2.96%, NUS is not doing good in the industry: 77.78% of the companies in the same industry are doing better.

NUS has a worse Return On Invested Capital (1.68%) than 81.48% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for NUS is below the industry average of 8.90%.

		Industry Rank	Sector Rank
ROA	-1.28%
ROE	-2.96%
ROIC	1.68%

ROA(3y)2.31%

ROA(5y)1.38%

ROE(3y)5.41%

ROE(5y)3.13%

ROIC(3y)5.35%

ROIC(5y)4.03%

1.3 Margins

In the last couple of years the Profit Margin of NUS has grown nicely.

Looking at the Operating Margin, with a value of 2.27%, NUS is doing worse than 81.48% of the companies in the same industry.

In the last couple of years the Operating Margin of NUS has declined.

NUS has a Gross Margin (40.90%) which is in line with its industry peers.

In the last couple of years the Gross Margin of NUS has declined.

		Industry Rank	Sector Rank
OM	2.27%
PM (TTM)	N/A
GM	40.9%

OM growth 3Y5.79%

OM growth 5Y-4.26%

PM growth 3Y9.01%

PM growth 5Y9.59%

GM growth 3Y7.06%

GM growth 5Y-2.06%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

Compared to 1 year ago, NUS has about the same amount of shares outstanding.

The number of shares outstanding for NUS has been increased compared to 5 years ago.

Compared to 1 year ago, NUS has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that NUS is in the distress zone and has some risk of bankruptcy.

NUS has a worse Altman-Z score (1.46) than 77.78% of its industry peers.

NUS has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.

NUS has a Debt to Equity ratio of 0.24. This is in the better half of the industry: NUS outperforms 77.78% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.24
Debt/FCF	N/A
Altman-Z	1.46

ROIC/WACC0.26

WACC6.39%

2.3 Liquidity

A Current Ratio of 1.67 indicates that NUS should not have too much problems paying its short term obligations.

NUS has a better Current ratio (1.67) than 70.37% of its industry peers.

A Quick Ratio of 1.17 indicates that NUS should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.17, NUS is in the better half of the industry, outperforming 77.78% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.67
Quick Ratio	1.17

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -128.88%.

The Earnings Per Share has been growing by 24.44% on average over the past years. This is a very strong growth

NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.48%.

Measured over the past years, NUS shows a very strong growth in Revenue. The Revenue has been growing by 21.43% on average per year.

EPS 1Y (TTM)-128.88%

EPS 3Y28.29%

EPS 5Y24.44%

EPS Q2Q%-116.98%

Revenue 1Y (TTM)-15.48%

Revenue growth 3Y27.23%

Revenue growth 5Y21.43%

Sales Q2Q%-6.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

NUS's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	8.26

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NUS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NUSCO SPA

BIT:NUS (12/4/2025, 7:00:00 PM)

0.775

-0.02 (-1.9%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryBuilding Products

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.71%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap15.46M

Revenue(TTM)49.52M

Net Income(TTM)-791.70K

Analysts80

Price Target2.24 (189.03%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.31
P/FCF	N/A
P/OCF	6.4
P/B	0.58
P/tB	0.7
EV/EBITDA	8.26

EPS(TTM)-0.04

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.16

FCFYN/A

OCF(TTM)0.12

OCFY15.62%

SpS2.48

BVpS1.34

TBVpS1.1

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.28%
ROE	-2.96%
ROCE	3.12%
ROIC	1.68%
ROICexc	1.74%
ROICexgc	2.03%
OM	2.27%
PM (TTM)	N/A
GM	40.9%
FCFM	N/A

ROA(3y)2.31%

ROA(5y)1.38%

ROE(3y)5.41%

ROE(5y)3.13%

ROIC(3y)5.35%

ROIC(5y)4.03%

ROICexc(3y)5.81%

ROICexc(5y)4.37%

ROICexgc(3y)7.26%

ROICexgc(5y)5.4%

ROCE(3y)9.93%

ROCE(5y)7.49%

ROICexgc growth 3Y19.53%

ROICexgc growth 5Y4.04%

ROICexc growth 3Y18.73%

ROICexc growth 5Y1.56%

OM growth 3Y5.79%

OM growth 5Y-4.26%

PM growth 3Y9.01%

PM growth 5Y9.59%

GM growth 3Y7.06%

GM growth 5Y-2.06%

F-Score4

Asset Turnover0.8

Health

		Industry Rank	Sector Rank
Debt/Equity	0.24
Debt/FCF	N/A
Debt/EBITDA	2.05
Cap/Depr	279.96%
Cap/Sales	11.12%
Interest Coverage	250
Cash Conversion	78.11%
Profit Quality	N/A
Current Ratio	1.67
Quick Ratio	1.17
Altman-Z	1.46

F-Score4

WACC6.39%

ROIC/WACC0.26

Cap/Depr(3y)426.48%

Cap/Depr(5y)N/A

Cap/Sales(3y)16.45%

Cap/Sales(5y)19.12%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-128.88%

EPS 3Y28.29%

EPS 5Y24.44%

EPS Q2Q%-116.98%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-15.48%

Revenue growth 3Y27.23%

Revenue growth 5Y21.43%

Sales Q2Q%-6.75%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-79.02%

EBIT growth 3Y34.59%

EBIT growth 5Y16.25%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y89.99%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y119.48%

OCF growth 3YN/A

OCF growth 5YN/A

NUSCO SPA / NUS.MI FAQ

Can you provide the ChartMill fundamental rating for NUSCO SPA?

ChartMill assigns a fundamental rating of 2 / 10 to NUS.MI.

Can you provide the valuation status for NUSCO SPA?

ChartMill assigns a valuation rating of 0 / 10 to NUSCO SPA (NUS.MI). This can be considered as Overvalued.

Can you provide the profitability details for NUSCO SPA?

NUSCO SPA (NUS.MI) has a profitability rating of 2 / 10.

NUSCO SPA (NUS.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NUSCO SPA / NUS.MI FAQ

Can you provide the ChartMill fundamental rating for NUSCO SPA?

Can you provide the valuation status for NUSCO SPA?

Can you provide the profitability details for NUSCO SPA?